Stereotaxis Inc (STXS) stock price

Stereotaxis Inc (STXS) is a Healthcare · Medical Instruments & Supplies company listed on NYSE MKT. Price $1.30 (+0.78%), Market cap $0.18B, 52-week low–high $1.73 ~ $3.57.

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed to enhance the accessibility of Robotic Magnetic Navigation by reducing the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a Synchrony and SynX So

Key metrics

Financial statements, price targets, institutional (13F) holdings and related news for Stereotaxis Inc are updated in real time on BlackAll Trade.

Stereotaxis Inc financial summary

Analyst outlook

Key ratios · profitability · growth

Frequently asked questions

What is the current Stereotaxis Inc (STXS) stock price?

Stereotaxis Inc trades at $1.30 (+0.78%). Real-time quotes and charts are available on BlackAll Trade.

What is the Stereotaxis Inc (STXS) market cap?

Stereotaxis Inc has a market cap of about $0.18B.

What does Stereotaxis Inc (STXS) do?

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offer